BELLEI, Monica
 Distribuzione geografica
Continente #
NA - Nord America 7.427
EU - Europa 2.465
AS - Asia 2.180
SA - Sud America 310
AF - Africa 99
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.529
Nazione #
US - Stati Uniti d'America 7.312
GB - Regno Unito 899
CN - Cina 657
SG - Singapore 531
HK - Hong Kong 320
SE - Svezia 305
DE - Germania 301
BR - Brasile 246
IT - Italia 200
VN - Vietnam 148
RU - Federazione Russa 146
UA - Ucraina 142
TR - Turchia 137
FR - Francia 90
FI - Finlandia 87
JP - Giappone 85
CA - Canada 67
KR - Corea 64
BG - Bulgaria 58
IN - India 56
BE - Belgio 48
IE - Irlanda 43
AU - Australia 41
AR - Argentina 29
ID - Indonesia 28
MX - Messico 27
ZA - Sudafrica 27
EG - Egitto 26
NL - Olanda 26
IR - Iran 21
TN - Tunisia 21
MY - Malesia 17
BD - Bangladesh 16
MA - Marocco 15
TW - Taiwan 15
ES - Italia 14
IQ - Iraq 14
PL - Polonia 14
CH - Svizzera 11
CL - Cile 11
RO - Romania 11
BZ - Belize 10
AT - Austria 9
EC - Ecuador 9
NO - Norvegia 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
EE - Estonia 8
IL - Israele 8
AE - Emirati Arabi Uniti 7
UZ - Uzbekistan 7
DK - Danimarca 6
LT - Lituania 6
PK - Pakistan 6
PT - Portogallo 6
CO - Colombia 5
JO - Giordania 5
NZ - Nuova Zelanda 5
PH - Filippine 5
DZ - Algeria 4
LB - Libano 4
PA - Panama 4
RS - Serbia 4
UY - Uruguay 4
AZ - Azerbaigian 3
GR - Grecia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
BH - Bahrain 2
BO - Bolivia 2
HR - Croazia 2
MK - Macedonia 2
PY - Paraguay 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 12.525
Città #
Ashburn 991
Fairfield 797
Santa Clara 608
Southend 591
Woodbridge 498
Chandler 380
Houston 359
Singapore 328
Hong Kong 281
Jacksonville 271
Seattle 271
Wilmington 270
Cambridge 240
Ann Arbor 214
Dearborn 202
Hefei 180
Nyköping 177
Dallas 165
Beijing 133
London 125
Los Angeles 119
Chicago 110
Frankfurt am Main 81
New York 70
Redwood City 65
Izmir 63
San Diego 58
Sofia 58
Modena 57
Princeton 55
Eugene 50
Bremen 49
Seoul 47
Salt Lake City 46
Shanghai 41
Dublin 38
Council Bluffs 36
Buffalo 35
Helsinki 35
Tokyo 33
Ho Chi Minh City 31
Moscow 30
The Dalles 28
Hanoi 27
Columbus 23
Falls Church 23
Des Moines 22
Jakarta 22
Dong Ket 20
Elk Grove Village 19
San Jose 19
São Paulo 19
New Malden 18
Milan 17
Tampa 17
Toronto 17
Brussels 15
Ottawa 15
Paris 15
Nagoya 14
Norwalk 14
Palo Alto 14
Phoenix 14
San Mateo 14
Jambes 13
San Francisco 12
Brooklyn 11
Manchester 11
Munich 11
Nanjing 11
Rio de Janeiro 11
Turku 11
Atlanta 10
Boston 10
Buenos Aires 10
Cairo 10
Istanbul 10
Johannesburg 10
Lancaster 10
Reggio Nell'emilia 10
Belize City 9
Boardman 9
Giza 9
Guangzhou 9
Kuala Lumpur 9
Mexico City 9
Miami 9
New Delhi 9
Nuremberg 9
Stockholm 9
Amsterdam 8
Denver 8
Dulles 8
Leporano 8
Mumbai 8
Philadelphia 8
Sterling 8
Sydney 8
Albuquerque 7
Ankara 7
Totale 9.033
Nome #
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 Trial 873
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial 620
T-cell lymphoma in South America and Europe. 460
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project 452
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 426
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study 367
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy 336
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfom 323
The outcome of peripheral t-cell lymphoma patients failing first-line therapy: A report from the prospective, international t-cell project 318
Follicular lymphoma international prognostic index. 304
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 291
Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project 288
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study 287
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network 286
[The protective effect of cyclosporine A, carnitine, and Mg(2+) with ADP during calcium(2+)-dependent permeabilization of mitochondria by fatty acids and activation of NADH oxidation by an external pathway] 265
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 264
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results. 256
Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry 255
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials 245
T-cell lymphomas: where we are and where we a re moving forward 244
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi Study 243
A model for predicting the risk of developing mild anemia (MA) in patients with lymphoid malignancy. A study of the Gruppo Italiano Studio Linfomi (GISL) 234
Watchful waiting in low-tumorburden follicular lymphoma in the Rituximab era. Results of a F2 observational 232
T-cell project: an international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma 232
Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: Results of the central review of 573 cases from the T-Cell Project, an international, cooperative study 229
[Damage to calcium ion-loaded mitochondria by fatty acids and the protective effect of carnitine] 218
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: Results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL) 209
Changes in liver structure and function after short-term and long-term treatment of rats with dehydroepiandrosterone 209
Concerning the mechanism of increased thermogenesis in rats treated with dehydroepiandrosterone 208
Effect of cardiolipin on functional properties of isolated rat liver mitochondria 208
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: A report from the prospective international T-cell project 205
Changes in mitochondrial activity caused by ammonium salts and the protective effect of carnitine 203
Effects of single or multiple doses of L-carnitine on liver energetic metabolism of rats forced to run 200
Comparative studies of effects of dehydroepiandrosterone on rat and chicken liver 187
Follicular Lymphoma - treatment and prognostic factors. 186
The protecting effect of L-carnitine on Ca(2+)-loaded rat liver mitochondria 180
Clinicopathologic characteristics of angioimmunoblastics T-cell lymphoma (AITL): analysis of 243 cases from the International Peripheral T-cell Lymphoma Project. 179
Sources of intramitochondrial malate 177
Follicular lymphomas: is there a chance for cure? 175
Prognosis factors in low-grade Non-Hodgkin's lymphomas 172
Induction of thermogenic enzymes by DHEA and its metabolites 170
The effects of the ergosteroid 7-oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis 169
BEACOPP or no BEACOPP 169
Interaction of carnitine with mitochondrial cardiolipin 167
Effects of dehydroepiandrosterone and carnitine treatment on rat liver 165
The prognosis of follicular lymphomas: The F2-project 155
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials 149
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial 144
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 142
Totale 12.676
Categoria #
all - tutte 44.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021820 0 0 0 0 0 91 114 144 84 163 128 96
2021/20221.097 35 121 139 68 34 56 71 84 108 75 188 118
2022/20231.290 111 135 76 126 162 172 42 162 151 23 73 57
2023/20241.333 40 61 60 72 204 108 127 565 21 15 11 49
2024/20251.989 59 13 12 157 434 293 168 108 246 97 187 215
2025/20262.016 253 129 401 457 649 127 0 0 0 0 0 0
Totale 12.676